IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.925
EU - Europa 1.946
AS - Asia 543
AF - Africa 349
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 12.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.760
FI - Finlandia 543
IE - Irlanda 399
NG - Nigeria 348
CN - Cina 234
DE - Germania 219
IT - Italia 176
FR - Francia 163
CA - Canada 161
SE - Svezia 119
NL - Olanda 116
IN - India 107
GB - Regno Unito 82
TR - Turchia 80
IL - Israele 48
BE - Belgio 46
RU - Federazione Russa 36
HK - Hong Kong 26
SG - Singapore 15
IR - Iran 13
AT - Austria 10
CL - Cile 8
EU - Europa 8
JP - Giappone 5
TW - Taiwan 5
AU - Australia 4
BR - Brasile 4
CH - Svizzera 4
ES - Italia 4
PA - Panama 4
UA - Ucraina 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
EE - Estonia 3
RO - Romania 3
TH - Thailandia 3
BD - Bangladesh 2
GR - Grecia 2
HR - Croazia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AL - Albania 1
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.793
Salva come PNG Salva come JPEG
Città #
Wilmington 2.010
Chandler 1.882
San Mateo 776
Ann Arbor 609
Helsinki 543
Leawood 401
Dublin 398
Benin City 348
Lawrence 327
Princeton 327
Boardman 311
Ashburn 278
Fairfield 195
New York 184
Woodbridge 181
Shanghai 177
Paris 160
Toronto 158
Amsterdam 110
Pune 94
Kocaeli 80
London 73
Milan 72
Seattle 59
San Diego 57
Norwalk 49
Brussels 46
Monmouth Junction 44
Beijing 30
Falls Church 30
Moscow 27
Phoenix 18
Houston 16
Redmond 15
Redwood City 14
Cambridge 11
Des Moines 10
Falkenstein 10
Berlin 9
Tappahannock 9
Singapore 8
Terracina 8
Vienna 8
Abbiategrasso 7
Andover 7
Zhengzhou 7
Augusta 5
Florence 5
Frankfurt am Main 5
Hanover 5
Jacksonville 5
Chengdu 4
Mumbai 4
Sacramento 4
Samarate 4
San Jose 4
St Petersburg 4
Clearwater 3
Hangzhou 3
Hebei 3
Mestre 3
Osimo 3
Pozzuoli 3
Rogeno 3
Saint Paul 3
Santa Clara 3
Tallinn 3
Apo 2
Avigliano 2
Bangkok 2
Buffalo 2
Chongqing 2
Guangzhou 2
Gurgaon 2
Issiglio 2
Kaohsiung City 2
Kwun Hang 2
Las Vegas 2
Norfolk 2
Rotterdam 2
Saint Louis 2
Schwenksville 2
Sherbrooke 2
Taipei 2
Trento 2
Umeå 2
Valencia 2
Zagreb 2
Alcamo 1
Ardabil 1
Athens 1
Auckland 1
Belfast 1
Belgrade 1
Bergamo 1
Bitola 1
Bradford 1
Bratislava 1
Böblingen 1
Cairo 1
Totale 10.326
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 92
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 86
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 81
11Cl-choline PET/CT in imaging locally advanced prostate cancer 73
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 70
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 67
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 65
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 65
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 64
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 64
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 64
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 64
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 62
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 61
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 60
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 60
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 60
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 60
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 60
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 59
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 58
C-11-Methionine uptake in secondary brain epilepsy 58
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 58
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 57
Radiopharmaceuticals for breast cancer imaging 56
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 56
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 56
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 56
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 56
Evaluation of response: is F-18-FDG PET the answer? 55
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 55
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 55
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 55
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 54
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 54
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 53
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 52
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 52
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 52
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 52
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 51
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 51
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 51
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 51
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 51
Prone scintimammography in patients with non-palpable breast lesions 51
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 50
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 50
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 50
EANM procedure guideline for treatment of refractory metastatic bone pain 49
Cardiac and Acoustic Metastases in Relapsing Melanoma 49
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 49
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 49
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 49
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 49
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 49
A risk management approach for imaging biomarker-driven clinical trials in oncology 49
Nuclear medicine procedures in lung cancer 48
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 48
F-18-FDG PET/CT scans for children and adolescents 48
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 48
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 48
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 48
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 48
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 47
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 47
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 47
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 47
FDG PET/CT predictive role in follicular lymphoma 46
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 46
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 46
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 46
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 46
Consensus on molecular imaging and theranostics in prostate cancer 46
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL) 46
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis 46
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 45
Reply to comment on Pepe et al.: Somatostatin receptor SPECT 45
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) 45
Exploration of Disease Markers under Translational Medicine Model 45
Why New Journals? The Growth of the EJNMMI Family 45
Assessment of tumor response in malignant pleural mesothelioma 45
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 45
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 45
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 1-Statement of the Issue and a Review of Available Resources 45
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 45
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 45
Joint Practice Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localization in Oral/Oropharyngeal Squamous Cell Carcinoma 45
Radionuclide imaging of unexpected multifocal breast cancer: surgical implications 44
Shaping our future 44
Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit 44
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 44
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 44
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 44
Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT 44
F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy 44
A method to reduce acetonitrile amount in F-18-FDG synthesis 44
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data 44
PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? 43
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 43
Totale 5.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.427
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 0 20
2020/20213.889 38 50 45 17 37 1.227 544 278 734 501 38 380
2021/20221.919 161 17 62 414 37 28 73 260 161 129 486 91
2022/20235.108 748 197 462 560 456 462 10 410 947 432 346 78
2023/20242.007 220 320 585 174 63 301 150 129 51 14 0 0
Totale 12.943